Eléments de l'association

	Arabie saoudite	258
	Hanan Balkhy	9
	Arabie saoudite *Sauf* Hanan Balkhy"	253
	Hanan Balkhy *Sauf* Arabie saoudite"	4
	Arabie saoudite Et Hanan Balkhy	5
	Arabie saoudite Ou Hanan Balkhy	262
	*Corpus*	8450

List of bibliographic references

Number of relevant bibliographic references: 5.

Ident.	Authors (with country if any)	Title
000437	Sabeena Mustafa [Arabie saoudite] ; Hanan Balkhy [Arabie saoudite] ; Musa Gabere [Arabie saoudite]	Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach
000954	Khaled O. Alsaad [Arabie saoudite] ; Ali H. Hajeer [Arabie saoudite] ; Mohammed Al Balwi [Arabie saoudite] ; Mohammed Al Moaiqel [Arabie saoudite] ; Nourah Al Oudah [Arabie saoudite] ; Abdulaziz Al Ajlan [Arabie saoudite] ; Sameera Aljohani [Arabie saoudite] ; Sami Alsolamy [Arabie saoudite] ; Giamal E. Gmati [Arabie saoudite] ; Hanan Balkhy [Arabie saoudite] ; Hamdan H. Al-Jahdali [Arabie saoudite] ; Salim A. Baharoon [Arabie saoudite] ; Yaseen M. Arabi [Arabie saoudite]	Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study.
000C56	Mahmoud Aly [Arabie saoudite] ; Mohamed Elrobh [Arabie saoudite] ; Maha Alzayer [Arabie saoudite] ; Sameera Aljuhani [Arabie saoudite] ; Hanan Balkhy [Arabie saoudite]	Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update
000E37	Sabeena Mustafa [Arabie saoudite] ; Hanan Balkhy [Arabie saoudite] ; Musa N. Gabere [Arabie saoudite]	Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
001793	Yaseen Arabi [Arabie saoudite] ; Hanan Balkhy [Arabie saoudite] ; Ali H. Hajeer [Arabie saoudite] ; Abderrezak Bouchama [Arabie saoudite] ; Frederick G. Hayden [États-Unis] ; Awad Al-Omari [Arabie saoudite] ; Fahad M. Al-Hameed [Arabie saoudite] ; Yusri Taha [Arabie saoudite] ; Nahoko Shindo [Suisse] ; John Whitehead [Royaume-Uni] ; Laura Merson [Viêt Nam] ; Sameera Aljohani [Arabie saoudite] ; Khalid Al-Khairy [Arabie saoudite] ; Gail Carson ; Thomas C. Luke [États-Unis] ; Lisa Hensley [États-Unis] ; Abdulaziz Al-Dawood [Arabie saoudite] ; Saad Al-Qahtani [Arabie saoudite] ; Kayvon Modjarrad [États-Unis] ; Musharaf Sadat [Arabie saoudite] ; Gernot Rohde [Pays-Bas] ; Catherine Leport [France] ; Robert Fowler [Canada]	Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021